E
Andlauer Healthcare Group Inc. ANDHF
$37.71 -$2.99-7.35%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)
E
Sell 7/5/2023Downgrade
Andlauer Healthcare Group Inc. (ANDHF) was downgraded to E from D+ on 7/5/2023 due to a major decline in the valuation index, growth index and total return index. Operating cash flow declined 33.37% from $27.07M to $18.04M, earnings per share declined from $0.3462 to $0.2883, and EBIT declined 15.59% from $20.75M to $17.51M.
D
Sell 1/4/2023Downgrade
Andlauer Healthcare Group Inc. (ANDHF) was downgraded to D+ from C- on 1/4/2023 due to a decline in the volatility index.
C
Hold 12/1/2022Downgrade
Andlauer Healthcare Group Inc. (ANDHF) was downgraded to C- from C on 12/1/2022 due to a decline in the volatility index.
C
Hold 11/12/2020Upgraded
Andlauer Healthcare Group Inc. (ANDHF) was upgraded to C from D+ on 11/12/2020 due to a noticeable increase in the growth index and valuation index. Earnings per share increased from $0.13 to $0.1651, EBIT increased 21.25% from $8.15M to $9.88M, and total revenue increased 12.19% from $50.72M to $56.9M.
D
Sell 10/1/2020Downgrade
Andlauer Healthcare Group Inc. (ANDHF) was downgraded to D+ from C- on 10/1/2020 due to a decline in the volatility index.
C
Hold 9/1/2020Downgrade
Andlauer Healthcare Group Inc. (ANDHF) was downgraded to C- from C on 9/1/2020 due to a decline in the volatility index.
C
Hold 7/15/2020Upgraded
Andlauer Healthcare Group Inc. (ANDHF) was upgraded to C from E on 7/15/2020 due to a major increase in the total return index, growth index and valuation index. Earnings per share increased from $0.1428 to $0.162, EBIT increased 7.76% from $8.71M to $9.38M, and total revenue increased 7.38% from $56.59M to $60.77M.
E
Sell 5/8/2020None
Andlauer Healthcare Group Inc. (ANDHF) was downgraded to E from U on 05/08/2020.
Weiss Ratings